Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression

Diabetes Care

Volumn 26, Issue 2, 2003, Pages 452-457

  Hosszúfalusi, Nóra ^a   Vatay, Agnes ^a   Rajczy, Katalin ^b   Prohászka, Zoltán ^a   Pozsonyi, Eva ^b   Horváth, Laura ^a   Grosz, Andrea ^c   Gerõ, László ^a   Madácsy, László ^a   Romics, László ^a   Karádi, István ^a   Füst, George ^a   Panczél, Pál ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b National Institute of Haematology and Immunology Budapest   (Hungary)

^c Polyclin Hosp Bros St John's God ^*  (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DQB1 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; PANCREAS ISLET CELL ANTIBODY; TRIACYLGLYCEROL; AUTOANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BODY MASS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES IN ADULT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICAL ANALYSIS; ALLELE; BLOOD; COMPARATIVE STUDY; GENETICS; GENOTYPE; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ALLELES; AUTOANTIBODIES; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED;

EID: 0041591490     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.2.452     Document Type: Article

References (25)

1. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
2. Davies JL, Kawaguichi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farrall M, Barnett AH, Baln SC, Todd JA: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130-136, 1994
3. Cantor AB, Krischer JP, Cuthbertson DD, Schatz DA, Riley WJ, Malone J, Schwartz S, Quattrin T, Maclaren NK: Age and family relationship accentuate the risk of IDDM in relatives of patients with insulin dependent diabetes. J Clin Endocrinol Metab 80:3739-3743, 1995
4. Huang W, Connor E, DelaRose T, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK: Although DR3-DQB1* may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB110302 haplotype is implicated only in beta cell autoimmunity. J Clin Endocrinol Metab 81:1-5, 1996
5. Thomson G, Robinson WP, Kuhner MK, Joe S, Macdonald MJ, Gottschall JL, Barbosa J, Rich SS, Bertrams J, Baur MP, Partanen J, Tait BD, Schober E, Mayr WR, Ludvigsson J, Lindblom B, Farid NR, Thompson C, Deschamps I: Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 43:799-816, 1988
6. Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT: Specific genomic markers for HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med 164:345-350, 1986
7. Cavan DA, Bain SC, Barnett AH: Genetics of type 1 (insulin-dependent) diabetes mellitus. J Med Genet 29:441-446, 1992
8. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR: Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362, 1993
9. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
10. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissén M, Ehrnström BO, Forsén B, Snickars B, Lahti K, Forsblom C, Sarolanta C, Taskinen MR, Groop LC: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157, 1999
11. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay I, Shattock M, Bottazzo GF, Holman R, UKPDS 25: Autoantibodies to islet-cell cytoplasma and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997
12. Bosi E, Garancini MP, Poggiali F, Bonifacio E, Gallus G: Low prevalence of islet autoimmunity in adult diabetes and low predictive value of islet autoantibodies in the general adult population of northern Italy. Diabetologia 42:840-844, 1999
13. Pietropaolo M, Barinas-Mitchell E, Pietropaolo SL, Kuller LH, Trucco M: Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 49:32-38, 2000
14. Lohmann T, Kellner K, Verlohren HJ, Krug J, Steindorf J, Scherbaum WA, Seissler J: Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 44:1005-1010, 2001
15. Isomaa B, Almgren P, Henricsson M, Taskinen MR, Tuomi T, Groop L, Sarelin L: Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA). Diabetes Care 22:1347-1353, 1999
16. Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R: Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 42:608-616, 1999
17. Seissler J, De Sonnaville JJJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA: Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia 41:891-897, 1998
18. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215-1219, 1988
19. Gottsater A, Landin-Olsson M, Lernmark A, Fernlund P, Sundkvist G: Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients. Acta Diabetol 31:226-231, 1994
20. Marner B, Agner T, Binder C, Lernmark A, Nerup J, Mandrup-Poulsen T, Walldorff S: Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients. Diabetologia 28:875-880, 1985
21. Christie M, Delovitch TL: Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type I diabetes. Diabetes 39:653-659, 1990
22. Mustonen A, Ilonen J, Tiilikainen A, Kataja M, Akerblom HK: An analysis of epidemiological data in HLA-typed diabetic children. Diabetologia 28:397-400, 1985
23. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK: Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB10302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years: the Belgian Diabetes Registry. Diabetologia 36:1155-1162, 1993
24. Karjalainen J, Salmela P, Ilonen J, Surgel HM, Knip M: A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-886, 1989
25. Lohmann T, Sessler J, Verlohren HJ, Schröder S, Rötger J, Dahn K, Morgenthaler N, Scherbaum WA: Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20:524-529, 1997